NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1427019520 MD
Verify on CMS → Rudabah Hasan, MD
Endocrinology, Diabetes & Metabolism Physician in New Rochelle, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 585 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
39%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
20.2/100
▼ 63 pts below national avg 83.5 · Below average
Industry payments
$197.2
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rudabah Hasan, MD reported a CMS MIPS final score of 20.2/100 - below the 83.5 national average - and filed 5,162 Medicare Part D claims in 2023.
- 20.2/100
- MIPS score · -63 vs avg
- 5K
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1427019520 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1427019520
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-LOW 20.2/100
- RX-MID 5,162
- BOOK-LIGHT 797 in New York
- PHOTO-FINISH Bruce Wilson · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Hasan · this pro…
Hasan · this provider
20.2 MIPS pts
- Bruce Wilson · n…
Bruce Wilson
20.2 MIPS pts
- Sharon Miller · …
Sharon Miller
20.2 MIPS pts
- Joseph Rodriguez…
Joseph Rodriguez
20.3 MIPS pts
- Bachar Kurdi · n…
Bachar Kurdi
20.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rudabah Hasan, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
20 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rudabah Hasan, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Rudabah Hasan, MD writes more Part D claims than 83% of them and scores higher on MIPS quality than 3% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Rudabah Hasan, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Rudabah Hasan, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rudabah Hasan, MD?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
5,162 96% vs specialty avg
MIPS final score
20.2/100 63.3 pts vs avg
Specialty distribution in New York
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Rudabah Hasan, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 20.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1427019520 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/29/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
20.1972
Final Score
Measured-score avg: 83.5
0
Quality
67.324
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rudabah Hasan, MD. Source: openpaymentsdata.cms.gov.
Total received
$197
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Rudabah Hasan, MD. To verify Rudabah Hasan, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Rudabah Hasan, MD - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 39% generic, on 5,162 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
5,162
Total Claims
$2.7M
Total Drug Cost
585
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 12,751
- Total Day Supply
- 380,123
- Brand vs Generic
- 48% brand / 39% generic
- Brand Drug Cost
- $2.5M
- Generic Drug Cost
- $54K
Patient Demographics
- Average Patient Age
- 74.1 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 56, 65-74: 238, 75-84: 227, 85+: 64
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rudabah Hasan, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
583 claims
- Metformin Hcl
Metformin Hcl
327 claims
- Ozempic
Ozempic
263 claims
- Novolog Flexpen 217
Novolog Flexpen
217 claims
- Synthroid 181
Synthroid
181 claims
- Humalog Kwikpen U-… 155
Humalog Kwikpen U-100
155 claims
- Gabapentin 147
Gabapentin
147 claims
- Trulicity 126
Trulicity
126 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 583 |
| Metformin Hcl | 327 |
| Ozempic Semaglutide | 263 |
| Novolog Flexpen Insulin Aspart | 217 |
| Synthroid Levothyroxine Sodium | 181 |
| Humalog Kwikpen U-100 Insulin Lispro | 155 |
| Gabapentin | 147 |
| Trulicity Dulaglutide | 126 |
| Rosuvastatin Calcium | 109 |
| Jardiance Empagliflozin | 96 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NY →
All providers in New York →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Rudabah Hasan, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Rudabah Hasan, MD's 5,162 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Hasan, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (20.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Hasan.
One of 797 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New York, 5 are shown here.
Dr. Zinoviy Abelev
MD
Long Island City, NY
Dr. Jill Abelseth
M.D.
Albany, NY
Dr. Sherley Abraham
M.D.
New York, NY
Dr. Jennifer Abrams
DO
Brooklyn, NY
Dr. Naim Abrar
M.D.
Riverhead, NY
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Rudabah Hasan, MD's specialty? ▼
Rudabah Hasan, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in New Rochelle, New York. Credentials: MD.
How much does Rudabah Hasan, MD prescribe under Medicare Part D? ▼
In 2023, Rudabah Hasan, MD wrote 5,162 Medicare Part D claims totaling $2.7M in drug costs for 585 beneficiaries.
What is Rudabah Hasan, MD's Medicare quality score? ▼
Rudabah Hasan, MD has a CMS MIPS Final Score of 20.2/100 (Quality: 0, Cost: 67.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Rudabah Hasan, MD located? ▼
Rudabah Hasan, MD is located at 140 LOCKWOOD AVE, New Rochelle, NY, 10801. Phone: (914) 636-5700.
What is Rudabah Hasan, MD's NPI number? ▼
Rudabah Hasan, MD's National Provider Identifier (NPI) is 1427019520, issued on 03/29/2006.
Does Rudabah Hasan, MD prescribe more brand-name or generic drugs? ▼
Rudabah Hasan, MD's prescribing is 48% brand-name and 39% generic drugs by claim count, with $2.5M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Rudabah Hasan, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Rudabah Hasan, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rudabah Hasan, MD accept Medicare? ▼
Rudabah Hasan, MD appears in CMS Medicare data with 5,162 Part D claims and 585 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rudabah Hasan, MD's credentials? ▼
Rudabah Hasan, MD's NPI is 1427019520 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.